Novozymes has patented a composition for animal feed containing specific xylanase and arabinofuranosidase polypeptides. The invention aims to enhance xylose solubilization from maize, improving feed efficiency. The patent covers polynucleotides, vectors, and methods for production and use of the polypeptides. GlobalData’s report on Novozymes gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Data Insights Novozymes AS - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Novozymes, was a key innovation area identified from patents. Novozymes's grant share as of February 2024 was 46%. Grant share is based on the ratio of number of grants to total number of patents.

A recently granted patent (Publication Number: US11926852B2) discloses a composition comprising a glycoside hydrolase family 10 (GH10) polypeptide with xylanase activity and at least 80% sequence identity to a specific polypeptide, along with a glycoside hydrolase family 62 (GH62) polypeptide with arabinofuranosidase activity and at least 80% sequence identity to another specific polypeptide. The composition is designed to solubilize xylose from defatted destarched maize (DFDSM), with specific conditions and enzyme concentrations outlined for optimal performance. The GH10 and GH62 polypeptides together are shown to solubilize at least 2 times more xylose from DFDSM compared to when the GH62 polypeptide is not present, highlighting the synergistic effect of the two enzymes.

Furthermore, the patent also covers methods for solubilizing xylose from plant-based materials, specifically targeting those from the sub-family Panicoideae, such as maize and corn. By utilizing the composition comprising the GH10 and GH62 polypeptides, the method aims to efficiently release starch from these plant-based materials. The patent emphasizes the importance of sequence identity between the polypeptides and provides different percentage thresholds for optimal activity, ranging from 80% to 95%. Additionally, the inclusion of formulating agents, enzymes, and microbes in the composition is also mentioned, showcasing the versatility and potential applications of the disclosed technology in various industrial processes related to plant-based material processing.

To know more about GlobalData’s detailed insights on Novozymes, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies